Coronary Vasospasm and Myocardial Infarction

Classification and Mechanism

• The American College of Cardiology recognizes coronary vasospasm as a cause of myocardial infarction, classified as Type 2 MI, where coronary vasospasm and/or endothelial dysfunction create an imbalance between myocardial oxygen supply and demand, leading to myocardial necrosis 1
• Focal coronary spasm can cause complete or near-complete coronary occlusion of an epicardial artery, resulting in transmural ischemia 2, 3, 4
• Dysfunctional endothelium exposes smooth muscle to vasoconstrictors, such as catecholamines, thromboxane A2, serotonin, histamine, and endothelin 2, 3, 5
• An imbalance between vasodilator factors, such as prostacyclin and nitric oxide, and vasoconstrictor factors, such as endothelin and angiotensin II, favors vasoconstriction 2, 3, 4

Clinical Presentation and Risk

• Most vasospastic angina attacks resolve spontaneously without myocardial infarction, but prolonged spasm is the critical determinant for progression to infarction 2, 3, 6, 5, 4
• Syncope during chest pain episodes suggests severe ischemia from acute occlusion due to focal spasm 2, 3, 5
• Attacks occurring in clusters with early morning predominance, or circadian variation, are a key clinical feature indicating higher myocardial infarction risk 2, 3, 5, 4
• Multivessel disease is present in 19% of vasospastic angina patients, increasing myocardial infarction and death risk 2, 3, 5, 4
• Patients in the active "waxing phase" of vasospastic disease face an elevated risk of myocardial infarction and sudden cardiac death, with a cardiovascular death rate of 0.5% per year and myocardial infarction risk of 1.2% per year 7

Diagnostic Considerations

• The diagnosis of coronary vasospasm requires documentation of transient ST-segment elevation during chest pain that resolves when symptoms abate, typically responding to nitroglycerin 2, 3, 6, 5, 4
• Even angiographically normal coronary segments often harbor mural atherosclerosis on intravascular ultrasound, predisposing to localized endothelial dysfunction and spasm 2, 3, 5, 4
• Provocative testing with ergonovine is positive in up to 20% of patients with recent myocardial infarction, suggesting vasospasm as a contributing mechanism 7
• Spasm can occur simultaneously at multiple sites and may be superimposed on either obstructive or non-obstructive coronary disease 2, 3, 5, 4

Clinical Pitfalls

• The greater the number of diseased arteries with vasospastic tendency, the higher the risk of death or acute myocardial infarction during follow-up 7

Heart Attack Without Blockage: Mechanisms and Causes

Primary Mechanisms

• Heart attacks can occur without significant coronary artery blockage through several distinct mechanisms, most commonly coronary artery spasm, spontaneous coronary artery dissection (SCAD), microvascular dysfunction, and supply-demand mismatch (Type 2 MI) 8, 9
• Intense focal spasm of epicardial coronary arteries can cause complete or near-complete vessel occlusion, resulting in transmural ischemia and myocardial infarction even in the absence of obstructive disease 9
• Dynamic coronary obstruction can be caused by diffuse microvascular dysfunction due to endothelial dysfunction or abnormal constriction of small intramural resistance vessels 9
• Microvascular spasm, impaired dilation, and extramural microvascular compression can all cause myocardial ischemia without epicardial obstruction 10
• Women have a higher proportion of acute coronary syndrome caused by coronary microvascular dysfunction compared to classical plaque rupture 11, 12

Type 2 Myocardial Infarction (Supply-Demand Mismatch)

• Type 2 MI occurs when myocardial necrosis results from conditions other than coronary plaque instability, creating an imbalance between myocardial oxygen supply and demand 13
• Increased oxygen demand, such as fever, tachycardia, and thyrotoxicosis, can precipitate Type 2 MI 8, 9
• Reduced coronary blood flow, such as hypotension, and reduced oxygen delivery, such as anemia and hypoxemia, can also precipitate Type 2 MI 8, 9, 13

Clinical Recognition

• Patients may present with typical chest pain or atypical symptoms, including dyspnea, epigastric pain, shoulder/arm/back pain, fatigue, or weakness, particularly common in women 11, 12
• A purely anatomical diagnostic approach using invasive coronary angiography or coronary CT may fail to diagnose microvascular and/or vasospastic angina, leading to false reassurance when no obstructive lesions are identified 10

Treatment Implications

• Calcium channel blockers, such as diltiazem and nifedipine, acting alone or in combination with long-acting nitrates, are the cornerstone of treatment for vasospastic angina and prevent coronary arterial spasm in almost all patients 8, 14
• The American College of Cardiology recommends treating the underlying cause of oxygen supply-demand imbalance rather than reperfusion therapy for Type 2 MI 13

Myocardial Infarction Without Atherosclerosis or Complete Occlusion

Definition and Mechanisms

• Type 2 MI represents myocardial necrosis caused by conditions other than coronary plaque instability, creating an oxygen supply-demand imbalance without requiring atherosclerotic disease, and can occur through mechanisms such as increased oxygen demand, reduced oxygen delivery, and coronary embolism, as stated by the European Heart Journal and the American College of Cardiology 15, 16
• Type 1 MI (atherosclerotic plaque rupture/erosion) can occur with non-obstructive or even no visible coronary artery disease in 5-20% of cases, particularly in women, according to the American College of Cardiology and the European Heart Journal 16, 17, 18

Diagnostic Criteria

• MINOCA is formally defined as acute MI with no coronary stenosis ≥50% on angiography, occurring in 5-25% of all MI presentations, and requires elevated cardiac troponin, clinical evidence of ischemia, absence of obstructive CAD, and no alternative diagnosis, as defined by the European Heart Journal 18, 15

Pathophysiology and Prognosis

• Patients with NSTEMI typically have partially occluded coronary arteries leading to subendocardial ischemia, while STEMI usually involves complete occlusion causing transmural infarction, as described by the American College of Cardiology and the Journal of the American College of Cardiology 16, 19, 20
• Cardiac MRI is a key diagnostic tool, identifying the underlying cause in up to 87% of MINOCA patients, as reported by the European Heart Journal 18

Dehydration from Gastroenteritis as a Cause of Type 2 Myocardial Infarction

Mechanism and Classification

• Type 2 MI occurs when myocardial necrosis results from conditions other than coronary plaque instability, specifically when there is an imbalance between myocardial oxygen supply and demand, as recognized by the European Society of Cardiology 21
• The American College of Cardiology explicitly recognizes hypotension as a cause of type 2 MI, stating that conditions creating supply-demand imbalance—including profound hypotension—result in myocardial injury 22
• Dehydration from gastroenteritis can trigger type 2 MI through reduced oxygen delivery from hemoconcentration and potential anemia, as noted in a study published in Anaesthesia 23
• The European Society of Cardiology identifies hypotension, respiratory failure, and anemia as precipitants of type 2 MI, highlighting the importance of these factors in the development of type 2 MI 21

Diagnostic Approach

• When evaluating patients with gastroenteritis and cardiovascular risk factors, an ECG should be obtained to look for ST-segment changes, T-wave abnormalities, or new Q waves, as recommended by the European Heart Journal 21
• Cardiac biomarkers, such as high-sensitivity troponin, should be measured in patients with risk factors, as elevation indicates myocardial necrosis requiring further evaluation, according to the European Heart Journal 21

Critical Management Distinctions

• Type 2 MI from dehydration requires fundamentally different treatment than type 1 MI, with a focus on treating the underlying cause, such as aggressive rehydration, rather than pursuing reperfusion therapy, and avoiding fluid boluses in shock, as noted in the Circulation journal 22
• Aspirin and P2Y12 inhibitors are contraindicated in type 2 MI resulting from severe hemorrhage and anemia, which may accompany gastroenteritis, as stated in the Circulation journal 22

Prognostic Implications

• The 30-day mortality after AMI overall remains 7.8%, with substantial risk for recurrent MI (6.9% at 12 months), death, heart failure, and stroke, highlighting the importance of proper management and follow-up, as noted in the Circulation journal 22

Type 2 Myocardial Infarction

Clinical Presentation and Diagnosis

• The American College of Cardiology suggests that severe anemia, such as a hemoglobin level of 5 g/dL, represents a profound reduction in oxygen-carrying capacity, directly impairing myocardial oxygen delivery in patients with Type 2 myocardial infarction 24, 25, 26, 27
• The American College of Cardiology recommends considering Type 2 MI when conditions other than coronary artery disease create an imbalance between myocardial oxygen supply and demand, with anemia explicitly listed as a causative mechanism 24, 25, 26, 27
• The American Heart Association defines Type 2 MI as a condition where an imbalance between myocardial oxygen supply and demand occurs due to conditions other than coronary artery disease, with severe anemia being a potential cause 24, 25, 28

Pathophysiology and Mechanism

• Reduced oxygen delivery from severe anemia decreases oxygen-carrying capacity, contributing to the development of Type 2 MI 24, 25
• Potential hypotension from acute blood loss can further reduce coronary perfusion, exacerbating the oxygen supply-demand mismatch in Type 2 MI 24, 25

Classification and Diagnosis

• The American College of Cardiology states that Type 1 MI is excluded in cases where there is no evidence of atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection with intraluminal thrombus formation, making Type 2 MI a more appropriate diagnosis in cases of severe anemia 24, 25
• The American College of Cardiology recommends reserving Type 3 MI classification for cases where the mechanism is unclear, and biomarkers are unavailable, whereas Type 2 MI is more appropriate when a clear precipitating cause, such as severe anemia, exists 24, 25, 28